- Page 1 and 2:
World Journal of Gastroenterology W
- Page 3 and 4:
Phillip S Oates, Perth Ross C Smith
- Page 5 and 6:
Deepak N Amarapurkar, Mumbai Abhiji
- Page 7 and 8:
Trine Olsen, Tromsø Eyvind J Pauls
- Page 9 and 10:
Conor P Delaney, Cleveland Sharon D
- Page 11 and 12:
S Contents EDITORIAL TOPIC HIGHLIGH
- Page 13 and 14:
Contents ACKNOWLEDGMENTS APPENDIX A
- Page 15 and 16:
Verhulst PJ et al . Ghrelin and glu
- Page 17 and 18:
Verhulst PJ et al . Ghrelin and glu
- Page 19 and 20:
Verhulst PJ et al . Ghrelin and glu
- Page 21 and 22:
Verhulst PJ et al . Ghrelin and glu
- Page 23 and 24:
Verhulst PJ et al . Ghrelin and glu
- Page 25 and 26:
Verhulst PJ et al . Ghrelin and glu
- Page 27:
Online Submissions: http://www.wjgn
- Page 31:
Ishikawa T. Zinc during interferon
- Page 35 and 36:
Sitarz R et al . Gastroenterostoma
- Page 37 and 38:
Sitarz R et al . Gastroenterostoma
- Page 39 and 40:
Morais TC et al . Gastrointestinal
- Page 41 and 42:
Morais TC et al . Gastrointestinal
- Page 43 and 44:
Morais TC et al . Gastrointestinal
- Page 45 and 46:
Morais TC et al . Gastrointestinal
- Page 47 and 48:
Song MJ et al . Usefulness of PET/C
- Page 49 and 50:
A Sensitivity B Sensitivity C Sensi
- Page 51 and 52:
Song MJ et al . Usefulness of PET/C
- Page 53 and 54:
Song MJ et al . Usefulness of PET/C
- Page 55 and 56:
Bae GS et al . Anti-inflammatory ef
- Page 57 and 58:
Bae GS et al . Anti-inflammatory ef
- Page 59 and 60:
B Myeloperoxidase activity (U/mg pr
- Page 61 and 62:
A Time (h) - 1 3 6 NJ4 B Relative H
- Page 63 and 64:
A C Time (h) - 1 3 6 NJ4-2 B Relati
- Page 65 and 66:
Bae GS et al . Anti-inflammatory ef
- Page 70 and 71:
A Collagen staining (fold change) C
- Page 72 and 73:
CCl4/YGJ CCl4-13 wk CCl4-7 wk Contr
- Page 74 and 75:
CCl4/YGJ CCl4-13 wk CCl4-7 wk Contr
- Page 76 and 77:
liver and have potent proliferative
- Page 78 and 79:
A 8 wk 9 wk 10 wk 13 wk CCl4/YGJ CC
- Page 80 and 81:
Cheng JC. A Chinese Herbal Decoctio
- Page 82 and 83:
Singh R, Neo EN, Nordeen N, Shanmug
- Page 84 and 85:
etter patient tolerance with regard
- Page 86:
Key words: Intestinal alkaline phos
- Page 89 and 90:
Molnár K et al . iAP in pediatric
- Page 97 and 98:
Chung WC et al . Ulcer after gastre
- Page 99:
Yang HY et al . Early resection of
- Page 102 and 103:
indicate a later timing for radical
- Page 104 and 105:
Zhao WC, Zhang HB, Yang N, Fu Y, Qi
- Page 106 and 107:
level, or rapid enlargement of lesi
- Page 108 and 109:
Table 3 Area under the receiver ope
- Page 111 and 112:
Zhao WC et al . Prognostic factors
- Page 113 and 114:
Online Submissions: http://www.wjgn
- Page 116 and 117:
mV 0 2 4 6 8 cpm FD patients are sh
- Page 118 and 119:
COMMENTS Background Gastric motilit
- Page 120 and 121: thirds partial hepatectomy (PH) in
- Page 122: A Serum ALT (U/L) C Serum alkaline
- Page 126 and 127: REFERENCES 1 Schibler U. Circadian
- Page 132 and 133: positive patients were found to hav
- Page 134: Online Submissions: http://www.wjgn
- Page 140: 21 Tosolini M, Kirilovsky A, Mlecni
- Page 147 and 148: Diao TJ et al . NO and hepatopulmon
- Page 149 and 150: Gallegos M et al . Lymphogranuloma
- Page 151 and 152: Gallegos M et al . Lymphogranuloma
- Page 153 and 154: Online Submissions: http://www.wjgn
- Page 155 and 156: A Hadžić N et al . Diagnosis in B
- Page 157 and 158: Hadžić N et al . Diagnosis in BAA
- Page 159 and 160: A B Chung HJ et al . Choledocholith
- Page 161 and 162: Chung HJ et al . Choledocholithiasi
- Page 163 and 164: Online Submissions: http://www.wjgn
- Page 165 and 166: Instructions to authors ISSN and EI
- Page 167 and 168: Instructions to authors AIM (no mor
- Page 169: Instructions to authors Guidelines